1. Home
  2. AXGN vs RA Comparison

AXGN vs RA Comparison

Compare AXGN & RA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXGN
  • RA
  • Stock Information
  • Founded
  • AXGN N/A
  • RA 2016
  • Country
  • AXGN United States
  • RA United States
  • Employees
  • AXGN N/A
  • RA N/A
  • Industry
  • AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RA Investment Managers
  • Sector
  • AXGN Health Care
  • RA Finance
  • Exchange
  • AXGN Nasdaq
  • RA Nasdaq
  • Market Cap
  • AXGN 797.9M
  • RA 741.9M
  • IPO Year
  • AXGN N/A
  • RA N/A
  • Fundamental
  • Price
  • AXGN $18.00
  • RA $13.43
  • Analyst Decision
  • AXGN Strong Buy
  • RA
  • Analyst Count
  • AXGN 3
  • RA 0
  • Target Price
  • AXGN $18.33
  • RA N/A
  • AVG Volume (30 Days)
  • AXGN 329.1K
  • RA 280.8K
  • Earning Date
  • AXGN 02-25-2025
  • RA 01-01-0001
  • Dividend Yield
  • AXGN N/A
  • RA 14.73%
  • EPS Growth
  • AXGN N/A
  • RA N/A
  • EPS
  • AXGN N/A
  • RA N/A
  • Revenue
  • AXGN $180,855,000.00
  • RA N/A
  • Revenue This Year
  • AXGN $19.41
  • RA N/A
  • Revenue Next Year
  • AXGN $13.08
  • RA N/A
  • P/E Ratio
  • AXGN N/A
  • RA N/A
  • Revenue Growth
  • AXGN 18.79
  • RA N/A
  • 52 Week Low
  • AXGN $5.55
  • RA $11.89
  • 52 Week High
  • AXGN $19.19
  • RA $17.32
  • Technical
  • Relative Strength Index (RSI)
  • AXGN 51.69
  • RA 51.80
  • Support Level
  • AXGN $17.73
  • RA $13.36
  • Resistance Level
  • AXGN $18.80
  • RA $13.55
  • Average True Range (ATR)
  • AXGN 0.77
  • RA 0.08
  • MACD
  • AXGN -0.08
  • RA 0.00
  • Stochastic Oscillator
  • AXGN 52.96
  • RA 50.00

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

About RA Brookfield Real Assets Income Fund Inc.

Brookfield Real Assets Income Fund Inc. is a diversified, closed-end management investment company. Its investment objective is to seek a high total return, through high current income and secondarily, through the growth of capital. The Fund seeks to achieve its investment objective by investing in the real asset class, which includes the following: Real Estate Securities; Infrastructure Securities; and Natural Resources Securities (collectively, Real Asset Companies and Issuers). The Firm manages separate accounts, registered funds, and opportunistic strategies for institutional and individual clients, including financial institutions, public and private pension plans, insurance companies, endowments and foundations, sovereign wealth funds, and high-net-worth investors.

Share on Social Networks: